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Bacterial type III secretion system (T3SS) effector proteins are critical determinants of infection for many animal and plant
pathogens. However, monitoring of the translocation and delivery of these important virulence determinants has proved to be
technically challenging. Here, we used a genetically engineered LOV (light-oxygen-voltage) sensing domain derivative to moni-
tor the expression, translocation, and localization of bacterial T3SS effectors. We found the Escherichia coli O157:H7 bacterial
effector fusion Tir-LOVwas functional following its translocation and localized to the host cell membrane in discrete foci, dem-
onstrating that LOV-based reporters can be used to visualize the effector translocation with minimal manipulation and interfer-
ence. Further evidence for the versatility of the reporter was demonstrated by fusing LOV to the C terminus of the Shigella flex-
neri effector IpaB. IpaB-LOV localized preferentially at bacterial poles before translocation. We observed the rapid translocation
of IpaB-LOV in a T3SS-dependent manner into host cells, where it localized at the bacterial entry site within membrane ruffles.
Imaging the complex dynamics of bacterium-host cell interac-tions using light microscopy is a key step in understanding bac-
terial pathogenesis and identifying new possibilities to interfere
with the infection process. Central to the pathogenesis of many
Gram-negative bacteria is the type III secretion system (T3SS), an
organelle that facilitates the injection of effector proteins from the
bacterial cytoplasm into host cells. Effectors of pathogenic Esche-
richia coli, Shigella, Salmonella, and Yersinia perform very diverse
functions, including regulation of actin dynamics to facilitate their
own attachment or invasion, subversion of endocytic trafficking,
blocking of phagocytosis, modulation of apoptotic pathways, and
manipulation of innate immunity, as well as host responses (1, 2).
The use of innovative imaging assays and probes to study the
cellular microbiology of effector proteins is becoming common-
place as limitations in image capture, data processing, and suitable
probes are overcome. Current light microscopy methods to study
effectors include fluorescence resonance energy transfer (FRET),
fluorescent detection after secretion, direct fluorescence labeling,
and recombinant reporter assays following translocation (1). Each
method is designed to allow effectors to be analyzed at specific
points such as the time of injection, identification of interacting
host proteins, or final localization within host cells.
A FRET reporter for T3SS effector translocation has been used
in numerous studies such as one by Auerbach et al., wherein the
subset of immune cells targeted by injectedYersinia pestis effectors
during infection was determined (3). Mills et al. also used the
system to determine the timing and hierarchy of effector translo-
cation in enteropathogenic E. coli (EPEC) (4). For the study of
effector proteins, a commonly adopted approach involves fusing
the effector to a-lactamase reporter (5). The host cells are labeled
with the nonfluorescent CCF2/AM substrate that is rapidly con-
verted by cellular esterases to fluorescent CCF2. Excitation of the
coumarin moiety results in FRET to a fluorescein moiety that
emits a green fluorescence signal. Translocation of an effector
fused to TEM-1 induces catalytic cleavage of the CCF2 -lactam
ring, affecting the FRET. This produces a detectable and measur-
able change in CCF2 fluorescence from green to blue emission.
Fluorescent reporters that are detected after translocation have
also been used successfully to monitor the timing of effector de-
livery into host cells. The use of a split-green fluorescent protein
(GFP) system (6) overcomes the limitation of the type III secre-
tion system (T3SS) to secrete partially folded polypeptides by fus-
ing part of the GFP fluorophore to the effector and expressing the
remaining component in the host cell. Upon successful transloca-
tion, the two halves are united to form a functional molecule suit-
able for immunofluorescence, as demonstrated for Salmonella
SPI2 effectors (6). The use of such a system may also provide
spatial information as the final localization can be determined, a
marked advantage compared to the FRET-based system described
above.
Direct labeling of the effector has been achieved with a tetracy-
clinemotif tag (4Cys) fused to the Shigella effectors IpaB and IpaC.
The effectors are then detected using a fluorescein-based biarsenic
dye (FlAsH) that becomes fluorescent upon binding to the 4Cys
motive. FlAsH was successfully used to monitor Salmonella Ty-
phimurium effector translocation in real time. However, detec-
tion dyes are often toxic to eukaryotic cells, such as the biarsenic
dye in FlAsH (7) and CCF4 in FRET (5). Moreover, until now, no
reporter has allowed the generation of a fusion protein to detect
expression of the effector inside bacteria and its subsequent trans-
location into host cells in real time.
We have previously used derivatives of the LOV domain to
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monitor protein expression and purification (8). LOV domains
are light-sensing motifs found in diverse photoreceptor proteins
from bacteria, fungi, and plants (9). LOV domains bind the chro-
mophore flavin mononucleotide (FMN) and emit green fluores-
cence when irradiated with blue/UV light. Advantages of LOV
domains include their small size (10 kDa) combined with an
innate ability to acquire their flavin fluorophore from the cellular
environment. Using this approach we previously showed that the
LOV-domain variant iLOV is effective as a fluorescent reporter of
protein production from pET-based vectors (10). Addition of
iLOV did not impede functionality of the effector protein EspG
upon microinjection into normal rat kidney (NRK) cells, leading
to disruption of the Golgi apparatus, as had previously been ob-
served for EspG (11). However, EspG-iLOV fluorescence in NRK
cells could not be observed possibly due to its disperse localization
and/or a detection limitation of iLOVfluorescence within eukary-
otic cells.
Here, we sought to improve iLOV and determine whether ef-
fectors could be monitored during secretion through the T3SS
apparatus. To this end, we initially focused on the translocated
intimin receptor (Tir) and the mitochondrial associated protein
(Map). The observation that enterohemorrhagic E. coli (EHEC)
translocates its own receptor into mammalian cells was described
more than a decade ago (12). Tir inserts into the plasma mem-
brane in a hairpin-loop conformation consisting of an extracellu-
lar domain flanked by two transmembrane and N- and C-termi-
nal cytoplasmic domains (13). The extracellular domain of Tir
binds Intimin on the bacterial cell surface, triggeringmultimeriza-
tion, and clustering of Tir beneath attached bacteria (14). Elegant
studies have demonstrated that EHEC Tir then binds a second
effector, EspFu (also termed TccP) triggering the activation of
N-WASP-Arp2/3-mediated actin assembly (15, 16). This activa-
tion initiates downstream signaling events, leading to the forma-
tion of the characteristic actin-rich pedestals.
Map, named according to its cellular target, is also a well-char-
acterized effector. Map has been demonstrated to possess three
distinct and independent functions. First, it interferes with the
cellular ability to maintain mitochondrial membrane potential,
triggering mitochondrial swelling and damage (17). Second, in
initial stages of EHEC infection, Map is responsible for the tran-
sient formation of filopodium-like structures at the sites of bacte-
rial infection (18). Third, Map is essential for disruption of intes-
tinal barrier function and alteration of tight junctions, an activity
that is independent of mitochondrial targeting (19).
Given that Tir and Map functionality are well understood, we
felt these effectors provided ideal candidates to evaluate whether
LOV can be used tomonitor T3SS translocation. Furthermore, we
evaluated the ability of LOV to track T3SS effector trafficking in
another bacterium, namely, Shigella flexneri. We focused on the
translocator/effector IpaB. This protein is produced and stored
intrabacterially before the contact with host cells that induces the
T3SS (20). Furthermore, it forms a complexwith IpaD at the tip of
the T3SS needle. It has previously been shown that prestored IpaB
is entirely released from the bacteria during host cell contact (7).
IpaB acts as a translocator, forming pores for the translocation of
other effector proteins. Within the host cells, IpaB has been sug-
gested to be involved in the activation of caspase-1 in macro-
phages and modulation of the cell cycle progression in epithelial
progenitor cells. Like Tir, IpaB is therefore well characterized and
provided an excellent model protein to test whether LOV can be
used to track effectors. We found that both Tir and IpaB could be
tagged with LOV and were successfully translocated into host
cells. Overall, our work shows that LOV domains can be used as
simple, genetically encoded reporters to monitor effector protein
expression and translocation.
MATERIALS AND METHODS
Generation of an E. coliO157:H7 strain expressing red fluorescent pro-
tein (RFP). Gene synthesis (DNA 2.0) was used to generate plasmid
pJ241-RFP, containing a gene encoding an enhanced RFP under the con-
trol of a pTAC promoter. The primers RfpFor (5=-GTGTCGCCCTTATT
CGACTCTAT-3=) and RfpRev (5=-CGCCCTTATTCGACTCACTATAG
AAGTTCC-3=) were used to amplify the RFP gene and the pTAC
promoter. The product was purified using a Qiagen PCR purification kit,
digested with BamHI, repurified, and then ligated using standard condi-
tions into the BamHI site of pAJR26 (21). Allelic exchange was performed
as previously described (22) using ZAP1193 (21), a derivative of strain
NCTC12900, as the recipient strain.
Creation of effector phiLOVexpression plasmids.DNA2.0was used
to synthesize plasmid, pJAG03 that facilitates in-frame cloning of effectors
and promoters with a variant of LOV, termed phiLOV. The primers Rfp-
For and ptacNdeIKpnI (5=-CTTCACCGGTACCAACCATATGTTATCC
TCC-3=) were used to amplify the pTAC promoter; this was then ligated
into pJAG03 to create pJAG07. Tir and its native promoter was digested
from pAJR133, gel purified, and ligated into pJAG03 to create the plasmid
pJAG13. The region encompassing the promoter and open reading frame
encoding the EHEC effectorMap was amplified using primers (5=-CGAG
ATCTGCACACTCCAGTATCCATTCA-3= and 5=-CGGGTACCCAATC
GGGTATCCTGTACATG-3=) from TUV93-0. The resulting product was
cloned into pJAG13 in place of Tir to create pCMQ1. To create pBAD-
IpaB-phiLOV, phiLOV was first amplified from pJAG13 using the prim-
ers XbaLOV (5=-CGTAGCTCTAGAATGATCGAGAAGAGCTTTG-3=)
and HindLOV (5=-CGTAGCAAGCTTTTAACGTGGTCGGAACCA-3=).
IpaB was amplified using the primers NdeIpa (5=-CGTAGCGCTAGCAT
GCATAATGTAAGCACCAC-3=) and XbaIpaB (5=-CGTAGCTCTAGAT
CAAGCAGTAGTTTGTTGCAAA-3=) to eliminate the native stop codon
and allow creation of the in-frame fusion. The PCR products were cloned
successively into pBAD18, creating pBADIpaB-phiLOV, and checked by
sequencing.
Measurement of relative fluorescence. ZAP193escN, a derivative of
NCTC12900 that is unable to secrete effectors, was transformed with
pJAG13 (pTir-phiLOV), pCMQ1 (pMap-phiLOV), or pAJR75 (pTir-
GFP). Bacteria were cultured overnight in Luria-Bertanimedium, subcul-
tured into minimal essential medium (MEM) containing 50 mMHEPES
in a 96-well plate to an optical density (OD) of 0.1, and grown at 37°C and
200 rpm, with readings taken at 600 and 488 nm every 30 min until an
OD of 0.8 was reached. The assay was performed in triplicate andmean
fluorescence readings corrected against a wild-type (WT) strain with
no plasmid.
Preparation of secreted proteins. Bacteria were cultured in 50 ml of
MEM-HEPES at 37°C and 200 rpm to an OD at 600 nm (OD600) of 0.8.
The bacterial cells were pelleted by centrifugation at 4,000 g for 10min,
and the supernatant was separated. The proteins were precipitated over-
night with 10% trichloroacetic acid (TCA), and separated by centrifuga-
tion at 4,000 g for 30min at 4°C. The proteins were suspended in 150l
of 1.5 M Tris-HCl (pH 8.8).
Immunoblotting. Proteins were separated by SDS-PAGE according
to standard methods, and Western blotting was performed as previously
describedwith-Tir (a gift fromTrinadChakraborty),-Sigma-70 (Neo-
clone), -LOV (8), and -calnexin antibodies (Pierce). For the secreted
proteins, cell culture supernatants were syringe filtered (0.45-m pore
size) and precipitated with 10% (vol/vol) TCA (Sigma) overnight at 4°C.
Secreted proteins were harvested by centrifugation at 4,000 rpm (4°C) for
1 h. Protein pellets were resuspended inTris-HCl (pH8.0), and equivalent
volumes were analyzed by SDS-PAGE. For the whole-cell fractions, 20g
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of total protein were loaded and probed. Experiments were repeated a
minimum of three times.
Bacterium-cell adhesion assay. Bovine embryonic lung (EBL) and
HeLa cells were seeded onto coverslips in a 24-well plate with ca. 60%
confluence and incubated overnight at 37°Cwith 5%CO2. EHECbacteria
were cultured in 50 ml of MEM supplemented with 50 mM HEPES and
antibiotics as required. The cultures were incubated at 37°C and 200 rpm
until an OD600 of 0.6 was reached. The bacteria were diluted with warm
MEM-HEPES and added to the cells at an approximate multiplicity of
infection of 30. The 24-well plate was centrifuged at 400  g to initiate
bacterial contact with the eukaryotic cells. The plate was then incubated at
37°Cwith 5%CO2. For the induction of the S. flexneriT3SS, bacteria were
cultured in tryptic soy broth containing chloramphenicol and Congo red.
Host cell membrane purification. Bacterial cell adhesion assays were
performed as described above. After 4 h of EHEC adhesion to EBLs, the
cells were treated with 50 g of gentamicin/ml at 37°C for 30 min to
remove all bacteria. The host cells were then trypsinized and washed, and
the host cell components were separated by using aMem-PER eukaryotic
membrane protein extraction reagent kit (Pierce), as described by the
manufacturer.
Real-timebacterium-cell adhesion assay.HeLa cells were seeded into
96-well Nunc plates with ca. 60% confluence and incubated overnight at
37°C with 5% CO2. The following day the cells were labeled with Cell-
Trace-DDAO to prepare them for imaging. Bacteria were cultured in 10
ml of MEM without phenol red (MEM-no phenol red; Sigma) supple-
mentedwith 50mMHEPES and antibiotics as required. The cultureswere
incubated at 37°C and 200 rpm until an OD600 of 0.6 was reached. The
bacteria were diluted with warmMEM, 50mMHEPES, and added to cells
at an approximate multiplicity of infection of 20. The 96-well plate was
centrifuged at 400 g to initiate bacterial contact with theHeLa cells. The
plate was washed every 60 min to prevent overgrowth of unattached bac-
teria in media. The expression and translocation of individual bacteria
was monitored (see Fig. 4e for a single example). Some 15 bacteria were
measured in this manner; however, they attach to host cells at different
rates, resulting in the population being nonsynchronous. As a technical
point, we found that HeLa cells were more suitable for fluorescence im-
aging over extended periods since they were better able to tolerate re-
peated exposure to ultraviolet light compared to the EBLs. HeLa cells have
been used successfully to study pedestal formation of both EPEC and
EHEC (23).
Fluorescence imaging. Fluorescence imaging, such as testing time
points for optimum expression and translocation, was performed using a
Zeiss AxioImager M1 widefield fluorescence microscope equipped with a
Hamamatsu Orca CCD camera and appropriate fluorescence filter sets.
Imaging of the precise localization of the Tir-phiLOV fusion during the
translocation process, such as those shown in Fig. 3d to h and Fig. 4a to d,
were obtained using a DeltaVision RT epifluorescence imaging system
(Applied Precision) and SoftWoRx software. Rapid three-dimensional
time-lapse imaging of Tir-phiLOV (Fig. 4e to h) and IpaB-phiLOV (Fig.
5) were obtained using a spinning disk confocal microscope using the
488-nm laser for phiLOV excitation (Perkin-Elmer). Data were captured
and analyzed using Volocity Suite software (Perkin-Elmer), allowing
quantification of two-dimensional (2D) images (pixels) or 3D images
(voxels).
RESULTS
phiLOV2.1, a derivative of the iLOVdomainwas used throughout
the study given its enhanced photostability and fluorescence (24).
Gene synthesis (DNA2.0) was used to codon optimize phiLOV2.1
to facilitate expression in E. coli and S. flexneri. The resultant do-
main, henceforth referred to as phiLOV, was cloned into pACYC
create pJAG03. The promoter region and coding sequence for the
EHEC effector proteins Tir and Map were cloned from strain
TUV93-0 into the pJAG03 backbone to create pJAG13 and
pCMQ1, respectively, as described in Materials and Methods. To
allow bacterial imaging without the need for antibody staining,
the gene encoding a red fluorescent protein (RFP) optimized for
bacterial expression was stably integrated into the EHEC genome
in place of lacZ.
To explore the properties of Tir-phiLOV and Map-phiLOV,
we evaluated their relative fluorescence when expressed in EHEC
under the control of their native promoters. Since it was possible
that phiLOV fusions might be secreted, expression studies were
performed in an EHEC T3SS-deficient strain that lacks the
ATPase (EscN) ensuring that all the fusion protein was retained in
the bacterial cytoplasm. This allowed for a more direct compari-
son between different reporters and constructs without the possi-
bility of protein secretion. Bacteria were cultured inMEM-HEPES
media to induce the expression of the T3SS and the level of fluo-
rescence for both phiLOV reporters monitored throughout the
growth phase. Fluorescence readings showed that Tir-phiLOV
was approximately three times brighter than Map-phiLOV (Fig.
1a). Indeed, we concluded that the expression of Map-phiLOV
was too low to warrant further study, a limitation we discuss fur-
ther below. To determine the relative expression of Tir-phiLOV
compared to existing GFP reporters, we also compared the Tir-
phiLOV reporter with a Tir-GFP reporter (pAJR75) (25). Both
FIG 1 Analysis of relative fluorescence of EHEC effector-phiLOV fusion
proteins under T3SS-inducing conditions. (a) EHEC expressing either Tir-
phiLOV or Map-phiLOV was grown under T3SS-inducing conditions to de-
termine whether expression of each effector could be measured using a simple
plate reader assay. Each effector-phiLOV fusion was measured in triplicate,
and the mean fluorescence was monitored over exponential growth. (b) Flu-
orescence of EHEC expressing either Tir-GFP or Tir-phiLOV was monitored
to determine how the Tir-phiLOV fusionwould perform directly compared to
Tir-GFP.
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plasmids comprised the same promoter sequence and plasmid
backbone, ensuring that the only variable was the fluorescent re-
porter being tested. The GFP reporter displayed fluorescence that
accumulated over time. In comparison, the phiLOV reporter was
less fluorescent, around 2.5 to 3 times less than the GFP through
the entire exponential phase (Fig. 1b). However, despite being less
fluorescent compared to GFP, the Tir-phiLOV reporter was de-
tectable on a simple fluorescence plate reader at similar growth
stages to Tir-GFP, suggesting that it would be readily imaged
within single cells.
To determine whether the Tir-phiLOV fusion could indeed be
secretedvia theT3SS,wild-typeEHECwas transformedwithpJAG13
and cultured in aMEM-HEPESmedia that induces expression of the
T3SS. Immunoblotting showed that the Tir-phiLOV fusion protein
was detectible in both whole-cell and secreted fractions (Fig. 2a).
Monitoring the levels of 70, a bacterial cytoplasmic protein, con-
firmed that Tir-phiLOV in the secreted fraction did not result
from bacterial cell lysis (Fig. 2a). Moreover, deletion of EscN
(escN), the ATPase required for T3SS activity, prevented export
of the Tir-phiLOV fusion protein, allowing detection only in the
whole-cell fraction (Fig. 2a). To compare the secretion of native
Tir and Tir-phiLOV, the secreted protein fractions from WT
EHEC and the WT transformed with pAJG13 were probed using
antibodies for Tir. This revealed both native Tir and Tir-phiLOV
in the supernatant of the transformed strain in equal amounts
(Fig. 2b).However, whenphiLOVwas expressed independently of
FIG 2 Analysis of Tir-phiLOV secretion and translocation. EHEC strains were cultured in T3SS-inducing conditions and harvested at an OD600 of 0.6. Samples
were centrifuged to yield the supernatant fraction (sn), and the bacterial pellet was lysed with Bugbuster (whole cell [wc]). (a) EHEC and EHECescN
transformed with a pTir-phiLOV probed with -iLOV antibodies. An -70 immunoblot acted as a control for bacterial lysis. (b) Comparison of
Tir-phiLOV and Tir secretion from EHEC transformed with empty vector (	) or pJAG13 (
) after probing with an -Tir antibody. (c) EHEC
transformed with a pTAC-phiLOV plasmid probed with -iLOV antibodies shows no secretion into the supernatant. To test translocation, a bacterium-
host cell adhesion assay was performed using EHEC with either no plasmid (	) or pTir-phiLOV (
) on EBL eukaryotic cells. Four hours after addition
of the bacteria, the EBL cells were treated with gentamicin, harvested, and fractionated into cytoplasmic (cy), membranes (me), and lysed bacteria (wc).
The fractions were probed with -iLOV antibodies (d), -calnexin antibodies (e), and -70 antibodies (f), with the lysed bacteria acting as a positive
control (wc). (g) To evaluate whether Tir-phiLOV was functional, WT EHEC, atirmutant, and thetir/Tir-phiLOV strain were added to HeLa cells and
fixed at various time points after the infection. Condensation of host cell actin was visualized by use of Alexa Fluor-labeled phalloidin. Bacteria were
detected by addition of -O157 antibodies. Deletion of Tir reduces the ability of bacteria to attach to host cells and prevents condensation of host cell
actin, a trait that was restored by transformation with the plasmid expression Tir-phiLOV.
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Tir, phiLOV was only detected in bacterial whole-cell fractions,
indicating that the fluorescent tag itself is not secreted indepen-
dently of the effector (Fig. 2c). These data supported the notion
that Tir-phiLOVcould be secreted via theT3SS, a key advantage of
the phiLOV reporter system over GFP.
The next question was to address whether Tir-phiLOV
could be translocated into eukaryotic cells. This was examined
using a bacterium-host cell adhesion assay. Bacteria expressing
Tir-phiLOV were used to challenge embryonic bovine lung
(EBL) epithelial cells for 240 min. Biochemical fractionation
showed that Tir-phiLOV was present in the eukaryotic mem-
brane (Fig. 2d), demonstrating that phiLOV could be translocated
into host cells. Eukaryotic membrane purity and the effective re-
moval of the bacteria were verified by immunoblotting for the
integral membrane protein -calnexin (Fig. 2e) and the bacterial
cytoplasmic protein 70, respectively (Fig. 2f).
Given that Tir-phiLOV was effectively secreted by the T3SS
and translocated into host cell membranes, the next key question
FIG 3 Imaging of Tir-phiLOV translocation. EHEC strains were transformed with pTAC-phiLOV or Tir-phiLOV and added to EBL eukaryotic cells. After 2 h,
the bacteria were fixed, and images were obtained and quantified. (a) WT EHEC transformed with Tir-phiLOV showed expression of the reporter after cell
contact. The bacterial cytoplasm was marked using the chromosomal RFP reporter and host cell actin stained using labeled phalloidin. (b and c) Expression and
localization of phiLOV (b) and Tir-phiLOV (c) of bacteria attached to host cells. The images show Z-slices from the “top” (slice 1) to the “bottom” (slice 9) of
attached bacteria. Areas of correlation between phiLOV and RFP are colored yellow, whereas pink shows areas where no correlation was measured. (d)
Quantification of the number of pixels associated with each Z-slice for the Tir-phiLOV, phiLOV, and bacterial RFP cytoplasmic channels (ZAP193A and -B). (e
to h) 3D, false-colored projections of the bacteria show that Tir-phiLOV (green) is spatially distinct from the bacterial cytoplasm (red). Areas of correlation
between phiLOV and RFP are highlighted using yellow with pink, showing areas where no correlation was measured. Representative images are shown; a
minimum of 10 individual bacteria were analyzed per experiment.
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was to determine whether it was functional. To address this ques-
tion, we performed cell infection assays usingWT EHEC, the tir
mutant, and thetirmutant expressing Tir-phiLOV.WTbacteria
could be seen to adhere intimately to the host cells, and the for-
mation of distinct pedestals could be seen after staining using
fluorescein isothiocyanate-phalloidin (Fig. 2g). This phenotype is
due to the accumulation of host cell actin after recruitment by Tir
at the site of bacterial attachment. Deletion of tir resulted in the
total absence of actin pedestals (Fig. 2g), a phenotype that could be
effectively rescued by Tir-phiLOV (Fig. 2g), showing that Tir-
phiLOV was both translocated and functional.
Having established that Tir-phiLOV is secreted, translocated,
and indeed functional, fluorescence microscopy was used to visu-
alize the expression of Tir-phiLOV within individual bacteria.
EBL cells were infected with EHEC expressing Tir-phiLOV. After
fixation, Tir-phiLOV expression could be seen in the vastmajority
(90%, n  300) of EHEC bound to the EBL cells (Fig. 3a) ap-
proximately 240 min after the initial infection. The level of Tir-
phiLOV expression varied considerably, a trait consistent with the
known heterogeneity associated with expression of LEE5 (25). In
order to ascertain whether Tir-phiLOV could be visualized after
its export, successive Z-slides were analyzed and compared to the
bacterial cytoplasmic channel, visualized using RFP. As a control,
phiLOV expressed independently of Tir was found to colocalize
very closely to the cytoplasmic RFP signal, demonstrating that in
the absence of an effector fusion phiLOV shows no distinct local-
ization pattern (Fig. 3b). In contrast, comparison of Tir-phiLOV
and the cytoplasmic channels showed a distinct localization, sug-
gesting that the fusion protein was localized adjacent to a propor-
tion of the bacteria (Fig. 3c). Quantification of the pixel density
associated with each channel demonstrated a clear difference in
the distribution of Tir-phiLOV compared to phiLOV alone (Fig.
3d). Analysis of successive Z-slices demonstrated that Tir-phiLOV
was indeed highly localized within individual bacteria and that a
high proportion of the fusion protein was localized directly adja-
cent to the bacterial cell (Fig. 3e and f), again in stark contrast to
expression of the phi-LOV domain alone, which showed excellent
colocalization with the bacterial cytoplasm (Fig. 3g and h).
Themajority of bacteria (60% at 60min postinfection, n 60)
were found to translocate Tir-phiLOV at a single well-defined
focal point, whereas a smaller proportion (30%, n 30) showed
two or, in some cases, several (10%, n 25) clearly defined areas
of Tir-phiLOV translocation, (Fig. 4a and b; see also Movie S1 in
the supplemental material), highlighting that effector trafficking
thatmay be highly targeted to selectedT3SS, and this subsequently
results in discrete translocation points into the host cell. Addi-
tional staining showed partial colocalization with host cell actin,
confirming our previous finding that Tir-phiLOVwas both trans-
located (Fig. 4c) and capable of mediating actin polymerization
(Fig. 4d). One caveat is that, since WT bacteria were used, the
variation in the number of foci observed may result from compe-
tition between native Tir and Tir-phiLOV for export by the T3SS.
Having established an optimum time frame for Tir-phiLOV
translocation, visualizing the localization of this effector was at-
FIG 4 Imaging of Tir-phiLOV colocalization with host cell actin and translocation in real-time. EHEC were transformed with Tir-phiLOV and added to HeLa
cells. (a and b) 3D, false-colored projections of the attached bacteria to show bacteria with multiple Tir-phiLOV foci. (c and d) 3D, false-colored projections of
the attached bacteria to show association of Tir-phiLOV with host cell actin (false-colored blue in panel d). (e) Real-time monitoring of Tir-phiLOV expression
and translocation from a single bacterium. (f to h) 3D false-colored projections of a 20-min time course of EHEC attachment and Tir-phiLOV expression on
HeLa cells. (f) EHEC (red) and Tir-phiLOV (green). (g) EHEC (red) with positive (yellow; overlap with green channel) and negative (purple; no overlap with
green channel) correlation channels. (h) The positive (yellow) and negative (purple) correlation of the red channel (EHEC) and green (Tir-phiLOV). Note the
negative correlation channel beside the area corresponding to the bacteria, indicating translocated Tir-phiLOV, and the positive channel indicates the overlap of
the red and green channels, indicating Tir-phiLOV still inside the bacteria.
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tempted in real time. The real-time imaging was challenging,
mainly due to the extended period required when monitoring the
infection process, taking hours rather than a few minutes. This
resulted in movement of the host cells and the attached bacteria,
making their imaging quite problematic.Moreover, phototoxicity
and photobleaching also become significant issues during re-
peated imaging. However, we did succeed in tracking bacteria for
a 50-min period after addition to host cells. Using spinning-disk
confocal microscopy, it was possible to measure both the cyto-
plasmic expression and translocation of Tir-phiLOV by indi-
vidual bacteria during the host cell attachment process (Fig.
4e). This imaging also highlighted the heterogeneity of Tir-
phiLOV expression with adjacent bacteria showing different
timing of Tir-phiLOV expression (Fig. 4f to h).
The simplicity of the phiLOV reporter makes it an attractive
tool that might be applied to study translocation events in a wide
range of T3SS-expressing bacteria. We wanted to test this poten-
tial wider applicability using a completely different pathogen and
effector combination. To this end, we tested ShigellaT3SS effector
translocation with an IpaB-phiLOV fusion. We chose IpaB be-
cause its secretion kinetics have been analyzed previously (7), it
can be modified at its C terminus without significantly impeding
its secretion, and its function has been analyzed in some detail (see
the introduction). It is expressed at high levels compared to other
effectors; therefore, it is a good candidate for the establishment
and validation of a new effector labeling approach. The fusion
protein was generated by cloning the sequences encoding ipaB
and phiLOV into pBAD18, thereby creating pBADIpaBphiLOV,
allowing inducible expression upon the addition of arabinose (see
Materials and Methods). An advantage of Shigella is that interac-
tions with host cells result in a rapid injection of T3SS effectors
and effects on the host cell in comparison to EHEC. Shigella effec-
tor translocation occurs within minutes rather than hours after
initial infection (7). When expressed in the WT S. flexneri strain
M90T, IpaB-phiLOV could be readily visualized within the bacte-
ria, yielding a typical polar localization that has been previously
identified for a number of bacterial effectors using different fluo-
rescent techniques (7, 26) (Fig. 5). Remarkably, after a time course
between 15 and 45 min of contact with the epithelial host cell line
HeLa, fluorescence was rapidly dissipated from the bacterial cyto-
plasm, a finding consistent with its translocation. On the other
hand, we could detect IpaB-phiLOV during the investigated time
course within the targeted HeLa cells in proximity to the invading
bacteria. IpaB-phiLOV localizationwithin host cells was similar to
the localization of IpaB using other fluorescent techniques (7)
highlighting the potential of the phiLOV labeling only minimally
perturbing the localization of the tagged effectors. As an addi-
tional control, an isogenic mxiD strain of S. flexneri was also
used. In this T3SS-deficient mutant, IpaB-phiLOV was retained
within the bacterial cell, and no attachment to host cells was ob-
served (Fig. 5). Quantification of the level of fluorescence within
the bacteria to that outside revealed the dramatic loss of the effec-
tor pool within the injecting bacteria. We also tested whether Shi-
gella invasion of HeLa cells was perturbed through the expres-
sion of IpaB-phiLOV. Scoring the number of entry foci as a
marker for ongoing bacterial uptake for M90T, M90T/IpaB-
phiLOV, M90T/phiLOV, and the noninvasive mutant mxiD/
IpaB-phiLOV, we could not detect a significant difference in
the number of entry foci for the WT strains expressing the
different fluorescently tagged proteins (Fig. 6). This showed
that IpaB-phiLOV expression did not perturb the entry of the
pathogen into the host cells.
FIG 5 Translocation of IpaB-LOV in Shigella flexneri. WT S. flexneri and an isogenic T3SS-deficient strain (mxiD) were transformed with the IpaB-phiLOV
construct. BacterialDNAandhost nuclei were stainedwithDAPI (blue), and actin focus formationwas tracked by using phalloidin-rhodamine (red). Before host
cell contact, IpaB-phiLOV localizes to the bacterial poles (upper panel and second panel). After translocation, it is located at the forming entry foci in the vicinity
of the bacterium (lower two panels).
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Previous studies have used a variety of technologies to monitor
effector protein translocation, including -lactamase, FlAsH/tet-
racysteine, and split-GFP approaches that require the two “halves”
of the protein to reassociate and mature for reporter activity (6).
Each approach has its inherent strengths and weaknesses that
have been reviewed extensively (1). The principal advantages of
phiLOV as a reporter are its intrinsic and oxygen-independent
fluorescence (27) combined with its small size. We also note in-
herent limitations. The Tir-phiLOV fusion was less fluorescent
than the equivalent GFP reporter, so for applications such as sim-
ple transcriptional readout, with no requirement for secretion,
GFP still provides the benchmark. Indeed, previous work has di-
rectly compared the quantumyields (QY) of LOV-based reporters
and shown them to be significantly lower (QY 0.2 to 0.4) to that
of GFP (QY 0.6) (28), which is consistent with our data.
Moreover, the native Tir promoter is strong, providing an am-
ple level of Tir-phiLOV that could be detected in both the bacte-
rium and the host membrane. In contrast, the expression of Map
was found to be too low to warrant detailed study using our ex-
perimental setup. Indeed, effector proteins with poorly defined or
weak native promoters might benefit from using the arabinose-
inducible plasmid thatwe used for the study of IpaB. The dramatic
loss of intrabacterially stored IpaB that we observed was previ-
ously detected using the 4Cys-FlAsH labeling approach (7). This
points at the efficiency of the ShigellaT3SS that is capable to trans-
locate large amounts of proteins within short periods of time. We
expressed IpaB in the present study and in the previous study
exogenously using a pBAD plasmid. It remains to be determined
how the activation of the T3SS affects the protein expression of
IpaB. Despite this, our data suggest that the rate of secretion is
much higher than the replenishment within the bacterium. It is
also worth noting that translocation of IpaB could be measured
within 15min, but not in real time, a trait we feel is likely to be due
to a requirement for maturation of the phiLOV effector fusion.
However, the inherent simplicity of being able to tag an effector
with a genetically encoded reporter andmonitor the entire expres-
sion and translocation process is clearly of huge benefit to re-
searchers. Tracking effectors using LOV derivatives also presents
the opportunity to perform correlative light electron microscopy
(CLEM), providing a further increase in resolution and insights
into effector functionality (29).
Collectively, the data presented here demonstrate the utility of
the phiLOV-based reporter system to effectively monitor T3SS
dynamics and effector protein trafficking at high resolution in a
spatial-temporal manner. When fused to Tir, phiLOV was
translocated through the T3SS and inserted into the host eu-
karyotic membrane. Crucially, in a tir strain, the expression
of Tir-phiLOV rescued the ability of the bacteria to form attach-
ing-and-effacing lesions upon host cell contact. This demon-
strates that Tir-phiLOV is functional upon its translocation. We
previously showed that EspG was also functional when tagged
with iLOV, a less fluorescent predecessor of phiLOV. Moreover,
using an entirely different pathogen and effector combination, we
showed that IpaB from S. flexneri could also be monitored using
phiLOV.
Further studies could couple reporter fusions for basal appa-
ratus proteins and phiLOV-tagged effectors to elegantly address
some of the questions raised by this study. For example, it would
be fascinating to dissect whether bacteria activate T3SS that are in
contact with host cells. Moreover, there is great potential for ap-
plying phiLOV to the study of other effectors to obtain a spatio-
temporal “map” of their subcellular localization during the infec-
tion process. This is particularly relevant since certain effectors
target multiple sites, for example, EspF, a multifunctional effector
with more than five proven eukaryotic targets (30). However, we
acknowledge that the reportermay not be suitable for all effectors.
Effectors with a low level of translocation would invariably be
much harder to detect andmay require strong inducible reporters
tomaximize their production. It would also be interesting to eval-
uate whether addition of the phiLOV fusion alters effector stabil-
ity in host cells. Elegant studies have shown that effectors can have
antagonistic functions and that degradation by host cell proteol-
ysis is central to their interplay (31). Again, the use of inducible
promoters might provide an effective way of controlling translo-
cation and allowing this interesting aspect of effector biology to be
further dissected.
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